Cellulose Dressing Vs Rayon Dressing in Skin Graft Donor Sites: Aspects of Patients’ Health-related QOL and Self-esteem
- Wed, 6/17/09 - 9:14am
- 0 Comments
- 3659 reads
Abstract: Objective. The aim of this study was to compare the health-related quality of life (HRQoL) and self-esteem of patients who underwent split-thickness skin grafting, when either cellulose dressings or rayon dressings were applied to the donor sites. Methods. A total of 25 patients, who were enrolled at five participant hospitals and required split-thickness skin grafting for various clinical reasons, were randomized into two treatment groups, the rayon dressing group (n = 13), or the cellulose dressing group (n = 12). All patients were assessed preoperatively and 60 days postoperatively. The HRQoL was assessed with the Short Form-36 (SF-36) health survey questionnaire, and self-esteem was evaluated using the Rosenberg Self-Esteem Scale (RSE)/UNIFESP-EPM (Brazilian versions). There were no surgery-related complications during the study period. Results. In both treatment groups, SF-36 scores for emotional role, mental health, vitality, and general health decreased from baseline. RSE scores increased from baseline in both treatment groups, showing a reduction in self-esteem after treatment. There was a statistical difference (P = 0.024) in the SF-36 bodily pain domain for the rayon group. Conclusion. There were no significant differences in HRQoL and self-esteem between treatment groups. In the rayon-dressing group, there was a significant decrease in bodily pain from baseline.
Address correspondence to:
Lydia M. Ferriera, MD, PhD
Federal University of São Paulo-UNIFESP
Division of Plastic Surgery
Rua Napoleao de Barros 715
4o andar
04023-062 São Paulo
Brazil
Phone: 55-11-5576-4118
E-mail: lydia.dcir@unifesp.epm.br
Split-thickness skin grafting is a procedure commonly used to replace damaged or missing skin.1 Donor site care has been widely studied,2–10 however, the health-related quality of life (HRQoL) of patients who have undergone this procedure needs further study. Many studies have been conducted on various types of dressings to determine which provides an optimal healing environment, pain relief, and is safe and easy to use.11–14
A skin-graft donor-site wound has the potential to affect many aspects of HRQoL of a patient, such as pain, functional capacity, social interaction, and self-esteem.
More recently there has been an increased interest in transforming the quality of life concepts into quantitative measurements that can be used in clinical and economic practices,15 and this initiative has played an important role in improving health services.16
In recent years, quality of life measurement tools have been widely used in clinical and research settings around the world, as well as in multinational, multicenter studies.15–17 Quality of life measurement tools may be applied at both individual and population levels. At the individual level, they can be used for assessing the severity and evolution of diseases, etiological factors, and therapeutic success. Additionally, they can be specific in assessing differences between populations, such as ethnicity, age, and socioeconomic structure.17
The aim of this study was to evaluate the impact of two different wound dressings applied to split-thickness skin graft donor sites on HRQoL and self-esteem of patients.
Methods
The Research Ethics Committee (CEP) of the Federal University of São Paulo (UNIFESP) approved the study. Written informed consent was obtained from all patients.
1. Feldman DL. Which dressing for split-thickness skin graft donor sites? Ann Plast Surg. 1991;27(3):288–291.
2. Brady SC, Snelling CFT, Chow G. Comparison of donor site dressings. Ann Plast Surg. 1980;5(3):238–243.
3. Gemberling RM, Miller TA, Caffee H, Zawacki BE. Dressing comparison in the healing of donor sites. J Trauma. 1976;16(10):812–814.
4. Kilinç H, Sensöz O, Ozdemir R, Unlü RE, Baran C. Which dressing for split-thickness skin graft donor sites? Ann Plast Surg. 2001;46(4):409–414.
5. Hallock GG. The cosmetic split-thickness skin graft donor site. Plast Reconstr Surg.1999;104(7):2286–2286.
6. Hagerty RC, Warm H. Primary closure of the split-thickness donor site. Plast Reconstr Surg. 1990;85(2):293–294.
7. Alvarez OM, Mertz PM, Eaglstein WH. The effect of occlusive dressings on collagen synthesis and re-epithelialization in superficial wounds. J Surg Res. 1983;35(2):142–148.
8. Varghese MC, Balin AK, Carter DM, Caldwell D. Local environment of chronic wounds under synthetic dressings. Arch Dermatol. 1986;122(1):52–57.
9. Ablaza VJ, Berlet AC, Manstein ME. An alternative treatment for the split-skin graft donor site. Aesthetic Plast Surg. 1997;21(3):207–209.
10. Wood RJ, Peltier GL, Twomey JA. Management of the difficult split-thickness donor site. Ann Plast Surg. 1989;22(1):80–81.
11. Butler PE, Eadie PA, Lawlor D, Edwards G, McHugh M. Bupivacaine and Kaltostat reduces post-operative donor site pain. Br J Plast Surg. 1993;46(6):523–524.
12. Hyland WT. A painless donor-site dressing. Plast Reconstr Surg. 1982; 69(4):703-704.
13. Tan ST, Roberts RH, Blake BG. Comparing DuoDERM E with scarlet red in the treatment of split skin graft donor sites. Br J Plast Surg. 1993;46(1):79–81.
14. Tan ST, Roberts RH, Sinclair SW. A comparison of Zenoderm with DuoDERM E in the treatment of split skin graft donor sites. Br J Plast Surg. 1993;46(1):82–84.
15. Ciconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR. Tradução para a língua portuguesa e validação do questionário genérico de avaliação de qualidade de vida SF-36. (Brasil SF-36). Rev Bras Reumatol. 1999;39(3):143–150.
16. Klassen A, Jenkinson C, Fitzpatrick R, Goodacre T. Patients’ health related quality of life before and after aesthetic surgery. Br J Plast Surg.1996;49(7):433–438.
17. McHorney CA. Measuring and monitoring general health status in elderly persons: practical and methodological issues in using the SF-36 Health Survey. Gerontologist. 1996;36(5):571–583.
18. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483.
19. Rosenberg M. Society and the adolescent self image. Princeton, NJ: Princeton University Press; 1965:326.
20. Dini GM, Quaresma MR, Ferreira LM. Adaptação cultural e validação da versão brasileira da escala de auto-estima de Rosenberg. Rev Soc Bras Cir Plast. 2004;19(1)41–52.
21. Melandri D, De Angelis A, Orioli R, et al. Use of a new hemicellulose dressing (Veloderm) for the treatment of split-thickness skin graft donor sites: A within-patient controlled study. Burns. 2006;32(8):964–972.
22. Santos DLN, Peixoto R. Biofill: Uso e avaliação clínica de uma película celulósica em lesões cutâneas. Rev Bras Cir. 1998;78(2):141–145.
23. Uysal AC, Alagoz S, Orbay H, Sensoz O. An alternative dressing material for the split-thickness skin graft donor site: oxidized regenerated cellulose. Ann Plast Surg. 2006;57(1):60–64.
24. Ferrell BR. The impact of pain on quality of life. A decade of research. Nurs Clin North Am. 1995;30(4):609–624.
25. Flett R, Harcourt B, Alpass F. Psychosocial aspects of chronic lower leg ulceration in the elderly. West J Nurs Res. 1994;16(2):183–192.
26. Franks PJ, Bosanquet N, Brown D, Straub J, Harper DR, Ruckley CV. Perceived health in a randomized trial of treatment for chronic venous ulceration. Eur J Vasc Endovasc Surg. 1999;17(2):155–159.
27. Franks PJ, Wright DD, Fletcher AE, et al. A questionnaire to assess risk factors, quality of life, and use of health resources in patients with venous disease. Eur J Surg. 1992;158(3):149–155.
28. Grocott P, Browne N, Cowley S. Quality of life: assessing the impact and benefits of care to patients with fungating wounds. WOUNDS. 2005;17(1):8–15.
29. Langemo DK. Quality of life and pressure ulcers: what is the impact? Impact of a pressure ulcer on health-related quality of life. WOUNDS. 2005;17(1):3–7.
30. O’Flynn L. The impact of minor acute wounds on quality of life. J Wound Care. 2000;9(7):337–340.
31. Pieper B, Szczepaniak K, Templin T. Psychosocial adjustment, coping, and quality of life in persons with venous ulcers and history of intravenous drug use. J Wound Ostomy Continence Nurs. 2000;27(4):227–237.
